Acetylsalicylic acid for primary prevention of cardiovascular events.
Year: 2019
Type: article
Abstract: Is acetylsalicylic acid (ASA) effective in reducing cardiovascular (CV) events in patients without preexisting CV disease (CVD)?
Three recent large RCTs of moderate-risk, elderly, and diabetic patients do not support the use of ASA for primary prevention. The potential absolute benefit of about 1
Source: PubMed Central
Authors: Paul Fritsch, Michael R Kolber
Institutions: University of Calgary, University of Alberta
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2963044206
